The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic.
about
Buprenorphine for neuropathic pain in adultsBuprenorphine for neuropathic pain in adultsBuprenorphine: a unique drug with complex pharmacologyBuprenorphine - an attractive opioid with underutilized potential in treatment of chronic painSubjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant usersPharmacological maintenance treatments of opiate addiction.Two cases of intranasal naloxone self-administration in opioid overdose.Organizational implementation of evidence-based substance abuse treatment in racial and ethnic minority communitiesThe reinforcing and subjective effects of intravenous and intranasal buprenorphine in heroin users.Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.Depression-like effect of prenatal buprenorphine exposure in rats.Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.Transdermal buprenorphine in the management of persistent pain - safety aspects.Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates.Pharmacologic treatments for opioid dependence: detoxification and maintenance options.Therapeutic options and challenges for substances of abuse.Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clustersThe Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level AnalysisAgonist-selective effects of opioid receptor ligands on cytosolic calcium concentration in rat striatal neuronsSublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.Buprenorphine dose induction in non-opioid-tolerant pre-release prisonersPressure Pain Sensitivity in Patients With Suspected Opioid-Induced Hyperalgesia.Pharmacotherapy treatment in substance-dependent correctional populations: a review.Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.Acute pain management for opioid dependent patients.Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversy.Controversies in translational research: drug self-administration.The role of human drug self-administration procedures in the development of medications.Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone.Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland.A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification.Differential antinociceptive effects of buprenorphine and methadone in the presence of HIV-gp120.Analgesic efficacy of buprenorphine in the presence of high levels of SDF-1α/CXCL12 in the brain.Buprenorphine for the treatment of perinatal opioid dependence: pharmacology and implications for antepartum, intrapartum, and postpartum care.Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research.Reducing the harm of opioid overdose with the safe use of naloxone : a pharmacologic review.Considerations on the role of buprenorphine in recovery from heroin addiction from a UK perspective.
P2860
Q24186924-7904813A-B96D-4FD9-95BA-5B154F53E529Q24187555-0E80ED75-8799-429C-B89F-D7CD745C963EQ24642980-50D21477-A639-4FFB-AA5B-B4B44599E454Q26775658-BFAA64C9-64CC-453B-8985-8CF6EB9B7FEAQ28284151-6541580C-F2E4-4E5B-8C8D-32E6BA35C3DAQ33582080-FA74F683-F919-4030-94CD-84819661EF8FQ33606282-899B38FD-A086-4415-B287-F21DA2E6DC6CQ33707278-6BDC9659-B38F-4155-8D44-7E9E65E0622AQ33889324-D47359F0-CC4D-401E-BFDB-7837951D62F2Q34186492-FBD6D16E-A7D9-4C76-9583-A722172EC4C5Q34485532-606C822A-261E-4701-9D2F-C41218BE3391Q34787766-441FB435-7808-4791-9F80-57B25848CC34Q35075284-99FE6A42-33B9-4966-8DD8-62408517B6E1Q35160035-2D55AD38-6284-48F6-A96C-C9ACBC723F3EQ35166793-11958917-5F30-4C83-89A4-678B05A9128CQ35222561-DD0BE6CB-5B76-4C2B-BBF8-797B371D5064Q35454866-90EBE8B0-480D-4A58-AD29-D9E33C2CE906Q35454891-5A346A8A-EBCD-4CE8-A142-F7FCECBE8DCAQ35687716-10B8DF1E-E18D-44DF-98BF-A699C533BC21Q35792939-900724EA-A6AF-47DE-AB7B-D009FDE881A0Q35828982-B586A06B-A07D-4A76-8868-EF90D674171AQ35875524-C319C6AF-569B-4A18-B7E0-470DC4B7DAEEQ36170053-14799235-1490-44E7-B197-FB7D3B408129Q36248890-0A6722EB-F8C4-4DDF-BEE2-443403AC6120Q36294335-1435477D-B4A4-4A86-B8E2-BD06B17EF8ADQ36311025-A768DB7B-1382-439B-B0B0-583069941A11Q36315633-42CA0D6D-FBFB-448F-8766-FD8E6C0F1A66Q36397280-CB758E70-810B-4238-A223-D4A6CF64B9E9Q36512881-AB2D8F1F-2646-4D5D-835E-D65C0C0E05C2Q37087986-3C50B083-B72B-4065-8D61-1CC07749B52FQ37147515-2EBCBB4C-C3B8-4205-997A-2F2EAB1392FFQ37204964-CE4B5C5F-4D24-4BBB-A20A-C90240A40ED4Q37248672-37812EC0-CAC3-4022-83B9-009B46E8482CQ37463807-398695DB-C614-4ED5-BB44-58ADE200F283Q37586875-40130819-1F4B-401F-977A-232DB2DBD57FQ37700823-E916F469-8D2F-43E2-B0FB-DDE0ED2BE774Q37871042-8DC11E12-C8EF-43CC-84FB-1CFA3972F363Q37999447-8664D7DD-FA6B-4AFB-8362-12AA59436A63Q38417339-241E8E80-F853-4DBB-BC7E-55E269876F75Q38562886-CE9AC37A-3FCE-4EA0-8F60-643E3FC76B57
P2860
The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The clinical pharmacology of b ...... the laboratory to the clinic.
@ast
The clinical pharmacology of b ...... the laboratory to the clinic.
@en
type
label
The clinical pharmacology of b ...... the laboratory to the clinic.
@ast
The clinical pharmacology of b ...... the laboratory to the clinic.
@en
prefLabel
The clinical pharmacology of b ...... the laboratory to the clinic.
@ast
The clinical pharmacology of b ...... the laboratory to the clinic.
@en
P1476
The clinical pharmacology of b ...... the laboratory to the clinic.
@en
P2093
Sharon L Walsh
Thomas Eissenberg
P304
P356
10.1016/S0376-8716(03)00056-5
P433
P577
2003-05-01T00:00:00Z